DE69217969T2 - METHODE UND LöSUNG ZUR BESTIMMUNG DER WIRKUNGSDAUER EINER AUF DIE HORNHAUT AUFGEBRACHTEN SUBSTANZ - Google Patents

METHODE UND LöSUNG ZUR BESTIMMUNG DER WIRKUNGSDAUER EINER AUF DIE HORNHAUT AUFGEBRACHTEN SUBSTANZ

Info

Publication number
DE69217969T2
DE69217969T2 DE69217969T DE69217969T DE69217969T2 DE 69217969 T2 DE69217969 T2 DE 69217969T2 DE 69217969 T DE69217969 T DE 69217969T DE 69217969 T DE69217969 T DE 69217969T DE 69217969 T2 DE69217969 T2 DE 69217969T2
Authority
DE
Germany
Prior art keywords
formulation
eye
fluorescently labelled
thin film
cornut
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69217969T
Other languages
English (en)
Other versions
DE69217969D1 (de
Inventor
Abhay Joshi
David Meadows
Jerry Paugh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of DE69217969D1 publication Critical patent/DE69217969D1/de
Application granted granted Critical
Publication of DE69217969T2 publication Critical patent/DE69217969T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/13—Ophthalmic microscopes
    • A61B3/135—Slit-lamp microscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
    • A61B3/1241—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes specially adapted for observation of ocular blood flow, e.g. by fluorescein angiography

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69217969T 1991-09-13 1992-09-08 METHODE UND LöSUNG ZUR BESTIMMUNG DER WIRKUNGSDAUER EINER AUF DIE HORNHAUT AUFGEBRACHTEN SUBSTANZ Expired - Fee Related DE69217969T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/759,530 US5323775A (en) 1991-09-13 1991-09-13 Diagnostic method for determining precorneal retention time of ophthalmic formulations
PCT/US1992/007567 WO1993005699A1 (en) 1991-09-13 1992-09-08 Diagnostic apparatus for determining precorneal retention time of ophthalmic formulations

Publications (2)

Publication Number Publication Date
DE69217969D1 DE69217969D1 (de) 1997-04-10
DE69217969T2 true DE69217969T2 (de) 1997-06-12

Family

ID=25056002

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69217969T Expired - Fee Related DE69217969T2 (de) 1991-09-13 1992-09-08 METHODE UND LöSUNG ZUR BESTIMMUNG DER WIRKUNGSDAUER EINER AUF DIE HORNHAUT AUFGEBRACHTEN SUBSTANZ

Country Status (7)

Country Link
US (2) US5323775A (de)
EP (1) EP0603338B1 (de)
AT (1) ATE149310T1 (de)
AU (1) AU2670892A (de)
DE (1) DE69217969T2 (de)
ES (1) ES2100362T3 (de)
WO (1) WO1993005699A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT101290B (pt) * 1993-06-18 2000-10-31 Fernandes Jose Guilherme Da Cu Fluorometro para medicao da concentracao de fluoroforos de localizacao ocular
US5553617A (en) * 1995-01-20 1996-09-10 Hughes Aircraft Company Noninvasive method and apparatus for determining body chemistry
US6179779B1 (en) 1997-12-22 2001-01-30 Ffhk Development Company Llc Replaceable prism system for applanation tonometer
US6736778B2 (en) 1997-12-22 2004-05-18 Francis Y. Falck, Jr. Replaceable prism for applanation tonometer
AU779659B2 (en) 2000-02-08 2005-02-03 Cornell Research Foundation Inc. Multiphoton excitation through optical fibers for fluorescence spectroscopy
JP2004518488A (ja) * 2000-11-02 2004-06-24 コーネル リサーチ ファンデーション インコーポレーテッド インビボ多光子診断的な神経変性疾患の検出および撮像
WO2005057244A2 (en) * 2003-08-19 2005-06-23 Cornell Research Foundation, Inc. Optical fiber delivery and collection system for biological applications
US20070089231A1 (en) * 2005-10-24 2007-04-26 Fendall, Inc. Emergency eyewash station having a peircing mechanism to puncture a sealed fluid bladder
US8316477B2 (en) * 2005-10-24 2012-11-27 Sperian Eye & Face Protection, Inc. Cartridge assembly for a self-contained emergency eyewash station
WO2007050525A1 (en) * 2005-10-24 2007-05-03 Sperian Eye & Face Protection, Inc. Emergency eyewash station having an expandable bellows waste collection system
WO2007050616A1 (en) * 2005-10-24 2007-05-03 Sperian Eye & Face Protection, Inc. Pump assembly for an emergency eyewash station
WO2007106847A2 (en) * 2006-03-15 2007-09-20 Sperian Eye & Face Protection, Inc. Emergency eyewash station and dispensing structure therefor
AU2008247423B2 (en) 2007-05-04 2013-10-31 Abbott Medical Optics Inc. Methods and devices for measuring tear film and diagnosing tear disorders
US7989404B2 (en) * 2008-02-11 2011-08-02 Clearwater International, Llc Compositions and methods for gas well treatment
GB2493568B (en) * 2011-08-09 2018-08-29 Zeiss Carl Meditec Ag Opthalmologic composition comprising an aqueous solution of at least one viscoelastic polysaccharide

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003991A (en) * 1974-08-27 1977-01-18 National Patent Development Corporation Ophthalmic formulation
US4120792A (en) * 1977-08-15 1978-10-17 Thiokol Corporation Combined filter and incinerator
US4120949A (en) * 1977-10-05 1978-10-17 Cooper Laboratories, Inc. Ophthalmic solution
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4407792A (en) * 1979-05-09 1983-10-04 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4597965A (en) * 1979-06-06 1986-07-01 Holles Laboratories, Inc. Method and composition for controlling corneal hydration
US4412543A (en) * 1981-04-09 1983-11-01 Xanar, Inc. Apparatus for determining the concentration of a fluorescent material in an eye
US4883351A (en) * 1982-09-10 1989-11-28 Weiss Jeffrey N Apparatus for the detection of diabetes and other abnormalities affecting the lens of the eye
US4895159A (en) * 1982-09-10 1990-01-23 Weiss Jeffrey N Diabetes detection method
US5025785A (en) * 1982-09-10 1991-06-25 Weiss Jeffrey N Diabetes detection method
US4540568A (en) * 1982-10-14 1985-09-10 Trager Seymour F Injectionable viscoelastic ophthalmic gel
US4573778A (en) * 1983-03-16 1986-03-04 Boston University Aqueous fluorophotometer
US4594326A (en) * 1983-05-09 1986-06-10 Wade Stephen E Time-integrated measurement for determining substances in biological fluids
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4711540A (en) * 1984-01-04 1987-12-08 Tokyo Kogaku Kikai Kabushiki Kaisha Eye disease inspecting instrument
US4711541A (en) * 1984-02-02 1987-12-08 Tokyo Kogaku Kikai Kabushiki Kaisha Slit lamp and accessory device thereof
SE454842B (sv) * 1984-11-01 1988-06-06 Pharmacia Ab Komposition for anvendning vid oftalmologiska applikationer innehallande en vattenlosning av en hogmolekyler polymer och ett lost polymert fergemne
US4702576A (en) * 1985-09-27 1987-10-27 Cambridge Instruments Inc. Ocular scattering analyzer
DE3542167A1 (de) * 1985-11-29 1987-06-04 Wolfgang Prof Dr Lohmann Verfahren zur messung der augen-linsen-truebung und anordnung zur durchfuehrung des verfahrens
CH671329A5 (de) * 1986-01-21 1989-08-31 Interzeag Ag
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4744980A (en) * 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US4842401A (en) * 1987-06-15 1989-06-27 The Board Of Trustees Of The Leland Stanford Jr. University Eye diagnosis process
US5171526A (en) * 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same

Also Published As

Publication number Publication date
ATE149310T1 (de) 1997-03-15
ES2100362T3 (es) 1997-06-16
DE69217969D1 (de) 1997-04-10
US5323775A (en) 1994-06-28
EP0603338B1 (de) 1997-03-05
WO1993005699A1 (en) 1993-04-01
AU2670892A (en) 1993-04-27
US5634458A (en) 1997-06-03
EP0603338A1 (de) 1994-06-29

Similar Documents

Publication Publication Date Title
DE69217969T2 (de) METHODE UND LöSUNG ZUR BESTIMMUNG DER WIRKUNGSDAUER EINER AUF DIE HORNHAUT AUFGEBRACHTEN SUBSTANZ
DE3779183D1 (de) Feste pharmaceutische zubereitung mit verlaengerter wirkstofffreigabe und verfahren zur herstellung.
ATE89723T1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
DE3678308D1 (de) Verfahren zur herstellung von mikrokapseln.
ATE7856T1 (de) Gamma-linolensaeuren enthaltende pharmazeutische und diaetetische zusammensetzung.
DE69105752T2 (de) Verfahren zur herstellung von florfenicol, seine analoga und oxazolinzwischenprodukte.
FR2422402A1 (fr) Composition a base d'ester 3-b-methoxyethylique et 5-isopropylique de 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl) pyridine, destinee a la therapeutique cerebrale
DE69401717D1 (de) Verfahren zur Aktivierung von polyanionischen,fluoreszierenden Farbstoffen in schwach dielektrischen Medien mit quaternären Oniumverbindungen
PT68066B (de) Verfahren zur herstellung von abformmaterialien insbesondere fur die zahnheilkunde
AT371708B (de) Verfahren zur herstellung von pharmazeutischen einheitsdosierungsformen
ATA540478A (de) Verfahren zur herstellung von optisch aktiven alpha-hydroxycarbonsaeuren
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
DE68924714T2 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
AT383123B (de) Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat
AT363936B (de) Verfahren zur herstellung von neuen cyproheptadinderivaten und von deren pharmazeutisch verwendbaren salzen sowie optischen isomeren
DE69027221D1 (de) Substituierte 4-phenyl-4-piperidincarboxamide mit sowohl lokalanästhetischer als auch schmerzlindernder wirkung sowie verfahren zur herstellung
DE3764700D1 (de) Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff.
ATA147676A (de) Verfahren zur herstellung von reiner traubensaure und von mesoweinsaure
AT360673B (de) Verfahren zur herstellung von neuen optisch aktiven 11-desoxy-16-aryl-omega-prostaglandinen
SE8801710L (sv) New ophtalmological composition of matter
FR2390157A1 (fr) Produit et procede pour le traitement de l'ivoire dentaire par le cerium
ATE78395T1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
ATE49402T1 (de) Verfahren zur herstellung von zirkoniumcarboxylat.
AT348986B (de) Verfahren zur herstellung von racemischen oder optisch aktiven alpha-(4'-alkylphenyl) alkansaeuren
AT367026B (de) Verfahren zur herstellung von 2-(2-hydroxyaethoxy) aethyl-n-(alpha,alpha,alpha-trifluor-m-tolyl) anthranilat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee